Tag: Ltee
-
Asmacure Ltee to Present at the 2011 BioPharm America Conference – MarketWatch (press release)
Asmacure Ltee to Present at the 2011 BioPharm America ConferenceMarketWatch (press release)1, 2011 /PRNewswire via COMTEX/ — Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases, announced today that CEO Martin Driscoll …and more » View full post on asthma – Google […]
-
Asmacure Ltee to Present at the 2011 BIO Business Forum During the Annual BIO … – PR Newswire (press release)
Asmacure Ltee to Present at the 2011 BIO Business Forum During the Annual BIO …PR Newswire (press release)QUEBEC CITY, June 22, 2011 /PRNewswire/ — Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases, announced today that CEO Martin …and more » View […]
-
Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran
Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases, announced today that Martin Driscoll has been appointed as chief executive officer. With a solid foundation established at Asmacure, Mr. […]